Sales rise 28.19% to Rs 10.46 crore
Net profit of Sandu Pharmaceuticals declined 62.96% to Rs 0.10 crore in the quarter ended September 2013 as against Rs 0.27 crore during the previous quarter ended September 2012. Sales rose 28.19% to Rs 10.46 crore in the quarter ended September 2013 as against Rs 8.16 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales10.468.16 28 OPM %4.026.99 -PBDT0.210.44 -52 PBT0.150.32 -53 NP0.100.27 -63Powered by Capital Market - Live News